Circulatory Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty (NCT06963320) | Livzon Pharmaceutical Group Inc. | 2025-01-20 |
| Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists (NCT02911155) | National Cancer Institute (NCI) | 2016-09-21 |
Track Circulatory Disease automatically
Every clearance here is in the API, with alerts when new ones post.